Investing Profile

Johannes Zanzinger

InvestorVC
Investment Manager at Boehringer Ingelheim Venture Fund
Photo of Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.3M - $17.0M
$8.5M
3
CompanyStageDateRound SizeTotal Raised
DiogenX
Series AMay 2023$37M
SeedJun 2020$5M
$42M
Co-investors: Katie Ellias (T1D Fund)
Centauri Therapeutics
Series AFeb 2022$33M
$33M
Co-investors: Sebastian Kreuz (Boehringer Ingelheim Venture Fund)